Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H11N3O4S2 |
Molecular Weight | 337.374 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1C(C(=O)NC2=NC=CS2)=C(O)C3=C(C=CC=C3)S1(=O)=O
InChI
InChIKey=SYCHUQUJURZQMO-UHFFFAOYSA-N
InChI=1S/C13H11N3O4S2/c1-16-10(12(18)15-13-14-6-7-21-13)11(17)8-4-2-3-5-9(8)22(16,19)20/h2-7,17H,1H3,(H,14,15,18)
Molecular Formula | C13H11N3O4S2 |
Molecular Weight | 337.374 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Sudoxicam is a nonsteroidal anti-inflammatory drug patented by American multinational pharmaceutical corporation Pfizer for the treatment of thrombosis. Sudoxicam strongly inhibited aggregation of rabbit, dog, and human platelets caused by collagen, but not by ADP. Sudoxicam inhibited the secondary phase of the biphasic response of guinea pig platelets to ADP and suppressed the release of ADP from human platelets caused by collagen. Sudoxicam shows superior anti-inflammatory activity compare to indomethacin in rat paw edema model. In clinical trials, sudoxicam was associated with several cases of severe hepatotoxicity that led to its discontinuation.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:26:41 GMT 2023
by
admin
on
Fri Dec 15 15:26:41 GMT 2023
|
Record UNII |
X033PDI962
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:26:41 GMT 2023 , Edited by admin on Fri Dec 15 15:26:41 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
54682951
Created by
admin on Fri Dec 15 15:26:41 GMT 2023 , Edited by admin on Fri Dec 15 15:26:41 GMT 2023
|
PRIMARY | |||
|
X033PDI962
Created by
admin on Fri Dec 15 15:26:41 GMT 2023 , Edited by admin on Fri Dec 15 15:26:41 GMT 2023
|
PRIMARY | |||
|
34042-85-8
Created by
admin on Fri Dec 15 15:26:41 GMT 2023 , Edited by admin on Fri Dec 15 15:26:41 GMT 2023
|
PRIMARY | |||
|
251-808-7
Created by
admin on Fri Dec 15 15:26:41 GMT 2023 , Edited by admin on Fri Dec 15 15:26:41 GMT 2023
|
PRIMARY | |||
|
3225
Created by
admin on Fri Dec 15 15:26:41 GMT 2023 , Edited by admin on Fri Dec 15 15:26:41 GMT 2023
|
PRIMARY | |||
|
C152447
Created by
admin on Fri Dec 15 15:26:41 GMT 2023 , Edited by admin on Fri Dec 15 15:26:41 GMT 2023
|
PRIMARY | |||
|
C100301
Created by
admin on Fri Dec 15 15:26:41 GMT 2023 , Edited by admin on Fri Dec 15 15:26:41 GMT 2023
|
PRIMARY | |||
|
100000083234
Created by
admin on Fri Dec 15 15:26:41 GMT 2023 , Edited by admin on Fri Dec 15 15:26:41 GMT 2023
|
PRIMARY | |||
|
SUB10670MIG
Created by
admin on Fri Dec 15 15:26:41 GMT 2023 , Edited by admin on Fri Dec 15 15:26:41 GMT 2023
|
PRIMARY | |||
|
CHEMBL20634
Created by
admin on Fri Dec 15 15:26:41 GMT 2023 , Edited by admin on Fri Dec 15 15:26:41 GMT 2023
|
PRIMARY | |||
|
DTXSID50187653
Created by
admin on Fri Dec 15 15:26:41 GMT 2023 , Edited by admin on Fri Dec 15 15:26:41 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |